Rua Life Sciences PLC (RUA) — Cash Flow-to-Debt Ratio
Rua Life Sciences PLC (RUA) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of GBX29.00K could theoretically repay 0% of its total liabilities (GBX1.89 Million) in one year. See Rua Life Sciences PLC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Rua Life Sciences PLC Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Rua Life Sciences PLC across 33 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Rua Life Sciences PLC.
Annual Cash Flow-to-Debt Ratio for Rua Life Sciences PLC (1994–2025)
Year-by-year debt coverage analysis for Rua Life Sciences PLC. Check Rua Life Sciences PLC cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | GBX-137.00K | GBX1.89 Million | ▲ +38.3% |
| 2025 | -0.12x | GBX-219.00K | GBX1.86 Million | ▲ +91.3% |
| 2024 | -1.35x | GBX-1.33 Million | GBX987.00K | ▼ -12.3% |
| 2023 | -1.20x | GBX-1.17 Million | GBX980.00K | ▲ +47.1% |
| 2022 | -2.27x | GBX-2.36 Million | GBX1.04 Million | ▼ -162.6% |
| 2021 | -0.86x | GBX-1.42 Million | GBX1.65 Million | ▲ +56.2% |
| 2020 | -1.97x | GBX-431.00K | GBX219.00K | ▲ +54.6% |
| 2019 | -4.33x | GBX-429.00K | GBX99.00K | ▼ -183.7% |
| 2018 | 5.18x | GBX347.00K | GBX67.00K | ▲ +364.1% |
| 2017 | -1.96x | GBX-159.62K | GBX81.41K | ▼ -365.2% |
| 2016 | 0.74x | GBX84.70K | GBX114.56K | ▲ +164.2% |
| 2015 | -1.15x | GBX-189.82K | GBX164.91K | ▼ -1335.9% |
| 2014 | -0.08x | GBX-24.00K | GBX299.38K | ▼ -108.2% |
| 2013 | 0.97x | GBX346.19K | GBX355.41K | ▲ +646.8% |
| 2012 | 0.13x | GBX50.59K | GBX387.88K | ▲ +105.6% |
| 2011 | -2.31x | GBX-1.53 Million | GBX660.00K | ▲ +29.7% |
| 2010 | -3.29x | GBX-2.05 Million | GBX623.00K | ▼ -40.0% |
| 2009 | -2.35x | GBX-1.39 Million | GBX591.00K | ▼ -50.2% |
| 2008 | -1.56x | GBX-1.14 Million | GBX728.00K | ▼ -37.3% |
| 2007 | -1.14x | GBX-816.00K | GBX716.00K | ▲ +42.3% |
| 2006 | -1.98x | GBX-1.29 Million | GBX652.00K | ▲ +67.6% |
| 2005 | -6.09x | GBX-2.12 Million | GBX348.00K | ▼ -174.7% |
| 2004 | -2.22x | GBX-971.00K | GBX438.00K | ▲ +56.7% |
| 2003 | -5.12x | GBX-11.93 Million | GBX2.33 Million | ▼ -3.5% |
| 2002 | -4.94x | GBX-12.99 Million | GBX2.63 Million | ▼ -190.5% |
| 2001 | -1.70x | GBX-4.28 Million | GBX2.52 Million | ▼ -136.4% |
| 2000 | -0.72x | GBX-2.02 Million | GBX2.81 Million | ▲ +33.9% |
| 1999 | -1.09x | GBX-1.44 Million | GBX1.32 Million | ▼ -9.6% |
| 1998 | -0.99x | GBX-1.37 Million | GBX1.38 Million | ▼ -60.3% |
| 1997 | -0.62x | GBX-956.00K | GBX1.54 Million | ▼ -292.4% |
| 1996 | 0.32x | GBX446.00K | GBX1.39 Million | ▲ +362.4% |
| 1995 | -0.12x | GBX-233.00K | GBX1.90 Million | ▼ -495.8% |
| 1994 | -0.02x | GBX-36.00K | GBX1.75 Million | — |